Elliott Ruiz is Senior Vice President of Finance and Operations at Neurvati Neurosciences and GRIN Therapeutics, overseeing finance, operations, and information technology. He began his career in investment banking at Truist Securities and also worked in the healthcare corporate finance group at KPMG. In 2014, Elliott transitioned into industry at Alvogen Inc., a privately held, private equity backed US specialty pharmaceutical company. At Alvogen, Elliott oversaw corporate development in addition to capital raising activities and financial planning and analysis. In 2016, Elliott joined Purdue Pharma to lead their business development finance team, ultimately serving as Treasurer overseeing business development, FP&A, treasury, accounts payable, credit, and insurance. Elliott’s leadership was battle-tested as he played an instrumental role in the company’s restructuring and settlement process. Elliott received his BA in economics from Cornell University and his MBA from the Darden School at the University of Virginia. He also earned executive leadership development certification at the Yale School of Management.